News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sandercock Colin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Sandercock Colin (SVP, GENERAL COUNSEL) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 60,000 options to buy
@ $6.91, valued at
$414.6k
Granted 16,667 options to buy
@ $5.01, valued at
$83.5k
|
|
| 02/12/2021 |
4
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $15.55, valued at
$777.5k
|
|
| 08/07/2020 |
4
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Sold 13,274 shares
@ $20, valued at
$265.5k
Exercised 13,274 options to buy
@ $7.5, valued at
$99.6k
|
|
| 08/05/2020 |
4
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Sold 6,425 shares
@ $20, valued at
$128.5k
Sold 201 shares
@ $20.05, valued at
$4k
Exercised 6,425 options to buy
@ $7.5, valued at
$48.2k
Exercised 201 options to buy
@ $7.5, valued at
$1.5k
|
|
| 02/12/2020 |
4
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $16.26, valued at
$325.2k
|
|
| 06/10/2019 |
4
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 2,000 shares
@ $7.1, valued at
$14.2k
Bought 14,938 shares
@ $7.93, valued at
$118.5k
|
|
| 03/08/2019 |
4
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $6.42, valued at
$321k
Granted 100,000 options to buy
@ $7.5, valued at
$750k
|
|
| 12/27/2017 |
4
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 150,000 options
@ $7.5, valued at
$1.1M
|
|
|
|